Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Niraparib 100mg capsules |
| BNF code | 0801050CJAAAAAA |
| Virtual Therapeutic Moiety | Niraparib |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Niraparib tosylate monohydrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 733733005 |
| Strength value numerator | 100.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | capsule.oral |
| Dose Form | |
| Formulation | Oral capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Zejula 100mg capsules (GlaxoSmithKline UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Niraparib 100mg capsules 56 capsule | |
| Niraparib 100mg capsules 84 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.